default author photo

Anne E. Schuind

PATH

2201 Westlake Avenue, Suite 200

Seattle, WA 98121

United States

SCHOLARLY PAPERS

1

DOWNLOADS

117

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Immunogenicity and Safety of Escherichia Coli-Produced Bivalent Human Papillomavirus Vaccine in Girls 9–14 Years of Age in Low- and Middle-Income Countries: Final Data of Randomized Controlled Trial

Number of pages: 34 Posted: 08 Nov 2024
Agogo Malaria Research Centre, PATH, Kwame Nkrumah University of Science and Technology, Ghana, PATH, PATH, Kwame Nkrumah University of Science and Technology, Ghana, International Vaccine Institute, International Centre for Diarrheal Disease Research (icddr,b), Government of the United States of America - HPV Serology Laboratory, PATH, Government of the United States of America - HPV Serology Laboratory, - Infectious Disease Division, PATH, PATH and - Infectious Diseases Division
Downloads 117 (608,822)

Abstract:

Loading...

Human papillomavirus (HPV), HPV vaccine, immunization, immunobridging, one-dose immunogenicity